A 6-month prospective survey of cutaneous drug reactions in a hospital setting

British Journal of Dermatology

Volumn 149, Issue 5, 2003, Pages 1018-1022

  Fiszenson Albala, F ^a   Auzerie, V ^a   Make, E ^a   Farinotti, R ^a   Durand Stocco, C ^a   Crickx, B ^a   Descamps, V ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Adverse cutaneous drug reaction; Hospital; Pharmacovigilance; Systemic drug

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CONTRAST MEDIUM; DIURETIC AGENT; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; SULFONAMIDE; SULFONE DERIVATIVE;

AUTOIMMUNE HEPATITIS; CONNECTIVE TISSUE DISEASE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ERYTHRODERMA; FATALITY; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPEREOSINOPHILIA; INCIDENCE; LIVER DYSFUNCTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; REVIEW; RISK FACTOR; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS; VIRUS HEPATITIS;

ADULT; DRUG ERUPTIONS; EXANTHEMA; FEMALE; FRANCE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HOSPITAL DEPARTMENTS; HOSPITALIZATION; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0346751968     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05584.x     Document Type: Review

References (14)

1. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358-63.
2. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001: 137: 765-70.
3. Rademaker M, Oakley A, Duffill MB. Cutaneous adverse drug reactions in a hospital setting. N Z Med J 1995; 108: 165-6.
4. Baune B, Kessler V, Patris S et al. latrogénie médicamenteuse à l'hôpital: enquête un jour donné. Presse Med 2003; 32: 683-8.
5. Bégaud B. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985; 40: 111-18.
6. Arora PN, Aggarwal SK, Ramakrishnan KR, Chattopadhyay SP. Drug eruptions. Indian J Dermatol 1989; 34: 75-80.
7. Descamps V, Valance A, Edlinger C et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-4.
8. Descamps V, Mahe E, Descamps D et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003: 148: 1032-4.
9. Regnier S, Descamps V, Boui M et al. Parvovirus B19 infection mimicking drug-induced hypersensitivity syndrome. Ann Dermatol Venereol 2000; 127: 505-6.
10. Rademaker M. Do women have more adverse drugs reactions? Am J Clin Dermatol 2001; 2: 349-51.
11. Sharma VK. Cutaneous adverse drug reactions: clinical pattern and causal agents. J Postgrad Med 2001; 47: 95-9.
12. Cutroneo PM, Arcoraci V, Cucinotta G et al. Adverse drug reactions in childhood. A drug surveillance study in Sicily. Recenti Prog Med 1998; 89: 290-5. (Italian).
13. Dennehy CE. Drug related illness in emergency department patients. Am J Health Syst Pharm 1996; 53: 1422-6.
14. Olivier P, Boulbes O, Tubery M et al. Preventability of adverse effects in a medical emergency service. Therapie 2001; 56: 275-8.